Azathioprine News and Research

RSS
Azathioprine is an immunosupressant used in organ transplantation, autoimmune disease such as rheumatoid arthritis or inflammatory bowel disease such as Crohn's disease and ulcerative colitis. It is a pro-drug, converted in the body to the active metabolites 6-mercaptopurine and 6-thioinosinic acid.
FDA approves Pfizer’s XELJANZ to treat rheumatoid arthritis

FDA approves Pfizer’s XELJANZ to treat rheumatoid arthritis

Abbott announces results from HUMIRA clinical studies on ulcerative colitis

Abbott announces results from HUMIRA clinical studies on ulcerative colitis

FDA approves Abbott’s HUMIRA to treat ulcerative colitis

FDA approves Abbott’s HUMIRA to treat ulcerative colitis

Abbott receives FDA approval for Humira to treat ulcerative colitis

Abbott receives FDA approval for Humira to treat ulcerative colitis

Researchers define new treatment for potentially fatal lung disease in patients with CVID

Researchers define new treatment for potentially fatal lung disease in patients with CVID

Tofacitinib shows promise in active ulcerative colitis

Tofacitinib shows promise in active ulcerative colitis

Alfa Wassermann, Salix enter license agreement for EIR formulation of rifaximin

Alfa Wassermann, Salix enter license agreement for EIR formulation of rifaximin

Bone age necessary to correctly interpret growth status in pediatric Crohn's disease

Bone age necessary to correctly interpret growth status in pediatric Crohn's disease

Measuring bone age should be part of routine care for pediatric patients with Crohn's disease

Measuring bone age should be part of routine care for pediatric patients with Crohn's disease

Data from Janssen’s SIMPONI Phase 3 study on ulcerative colitis

Data from Janssen’s SIMPONI Phase 3 study on ulcerative colitis

Three-drug combo harmful for patients with idiopathic pulmonary fibrosis

Three-drug combo harmful for patients with idiopathic pulmonary fibrosis

Salix first quarter total product revenue increases 62% to $171.1M

Salix first quarter total product revenue increases 62% to $171.1M

Takeda enters definitive agreement to acquire URL Pharma

Takeda enters definitive agreement to acquire URL Pharma

Top-line results from Shire's SPD476 phase 3 trial on diverticulitis

Top-line results from Shire's SPD476 phase 3 trial on diverticulitis

Juvenile arthritis affected kids are at a high risk of cancer: Study

Juvenile arthritis affected kids are at a high risk of cancer: Study

EMA CHMP issues positive opinion to MSD's REMICADE for treatment of pediatric UC

EMA CHMP issues positive opinion to MSD's REMICADE for treatment of pediatric UC

FDA allows marketing of Stratify JCV Antibody ELISA test for PML

FDA allows marketing of Stratify JCV Antibody ELISA test for PML

Researchers discover HS1.2 enhancer as the cause of SLE

Researchers discover HS1.2 enhancer as the cause of SLE

Mycophenolate mofetil superior to azathioprine for lupus nephritis

Mycophenolate mofetil superior to azathioprine for lupus nephritis

Salix third quarter total product revenue increases 81% to $146.2 million

Salix third quarter total product revenue increases 81% to $146.2 million

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.